Holistic Management of Treatment-Resistant Hidradenitis Suppurativa: A Cost-Effective Alternative to Biologics - A Case Report
Authors
Keywords:
- Hidradenitis suppurativa,
- Adalimumab resistance,
- Holistic treatment,
- Cost-effectiveness,
- Lymecycline,
- Case report
Abstract
Background: Adalimumab, the sole FDA-approved biologic for Hidradenitis Suppurativa (HS), demonstrates limited long-term efficacy with treatment resistance developing in approximately 40-60% of patients, while costing ₹240,000-360,000 annually in India. This case explores the potential of holistic intervention as a cost-effective alternative.
Case Presentation: A 54-year-old female with severe HS experienced no improvement after two years of adalimumab therapy, presenting with open wounds, purulent discharge and significant pain affecting quality of life. Following adalimumab discontinuation, a comprehensive holistic protocol was implemented including complete dairy elimination, stress management through yoga and exercise, lymecycline 408mg daily for one month with antioxidant supplementation for six months and sequential topical therapy (benzoyl peroxide wash, mupirocin until wound healing, then isotretinoin 0.025%).
Outcomes: Complete wound healing was achieved within 8 weeks, with sustained remission for 6 months representing the longest disease-free period in the patient's history. No adverse effects were reported and significant improvement in mental state and motivation was observed. Total treatment cost was approximately ₹2,000 (<5% of adalimumab therapy).
Conclusion: This case demonstrates that evidence-based holistic approaches can achieve superior clinical outcomes to expensive biologics in treatment-resistant HS, offering a reproducible, cost-effective therapeutic paradigm with potential for widespread healthcare implementation.
Downloads
References
Zouboulis CC, Desai N, Emtestam L, Hunger RE, et al. (2015) European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 29: 619-644. https://doi.org/10.1111/jdv.12966
Patil S (2018) Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa. Indian J Dermatol Venereol Leprol 84: 745-747. https://pubmed.ncbi.nlm.nih.gov/30289113/
(2023) Adalimumab: Uses, side effects and medicines. https://www.apollopharmacy.in/salt/Adalimumab
Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 375: 422-434. https://doi.org/10.1056/nejmoa1504370
Frew JW, Hawkes JE, Krueger JG (2018) A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000Res 7: 1930. https://doi.org/10.12688/f1000research.17267.1
Arenbergerova M, Gkalpakiotis S, Arenberger P (2010) Effective long-term control of refractory hidradenitis suppurativa with adalimumab after prior adalimumab failure. Int J Dermatol 49: 1445-1449. https://doi.org/10.1111/j.1365-4632.2010.04638.x
(2023) Nutritional factors and hidradenitis suppurativa.
Kesik F, Dogan-Gunaydin S, Fisunoglu M (2024) The impact of diet on hidradenitis suppurativa severity: A cross-sectional case-control study. Medicina (Kaunas) 60: 2107. https://doi.org/10.3390/medicina60122107
Danby FW (2025) Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol 73: S52-S54. https://doi.org/10.1016/j.jaad.2015.07.042
Caposiena RDC, Molinelli E, Brisigotti V, Offidani A, Bianchi L (2021) Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa. Clin Exp Dermatol 46: 86-92. https://doi.org/10.1111/ced.14388
(2022) Loss of efficacy of adalimumab in hidradenitis suppurativa. An Bras Dermatol 98: 367-371.
(2021) Economic analysis of the costs associated with Hidradenitis Suppurativa. J Med Econ 24: 1073-1082.
(2019) Cost-savings of adalimumab in hidradenitis suppurativa. J Eur Acad Dermatol 33: 1015-1021.
Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, et al. (2022) Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: The 1-year SOLACE study. J Eur Acad Dermatol Venereol 36: e112-e115. https://doi.org/10.1111/jdv.17598
(2025) Dairy-Free Recipes for HS. myHSteam. https://www.myhsteam.com/resources/dairy-free-recipes-for-hs
(2024) Hidradenitis suppurativa exercise guide. HS Foundation. https://www.myhsteam.com/resources/dairy-free-recipes-for-hs
Molinelli E, Gioacchini H, Marani A, Rizzetto G, Gambini D, et al. (2024) Topical and systemic retinoids in the management of hidradenitis suppurativa: A comprehensive literature review. Dermatol Ther (Heidelb) 14(5):1079-1091. https://doi.org/10.1007/s13555-024-01169-1
Bhukhan A (2022) Complementary and alternative treatments for hidradenitis suppurativa: A systematic review. J Integr Dermatol. https://jintegrativederm.org/doi/10.64550/joid.46083j25
Tirant M, Lotti T, Gianfaldoni S, Tchernev G, Wollina U (2018) Integrative dermatology - the use of herbals and nutritional supplements to treat dermatological conditions. Open Access Maced J Med Sci 6: 185-202. https://doi.org/10.3889/oamjms.2018.041
